BioGeneration Ventures

Foundation date

10/11/2006

Sector

#Investor

Subsector

BioGeneration Ventures (BGV) is a venture capital company, with a focus on early stage European biotech companies. The Company has a strong track record of significant financial returns through investing in innovations in healthcare and providing the expertise to build world-class teams. The Company manages over €250 million ($300 million) of funds investing in areas where true scientific innovations, the unmet medical need, and the potential to demonstrate a significant proof of concept all come together.

 BGV strives to work with founding teams to mature science and build companies. The Company uses its experience to guide progress into clinical trials, ultimately leading to successful drug development and value realisation for its investors. BGV applies its expertise in a rigorous process to select the most compelling opportunities with the best prospects for exit.

Upcoming events

Latest news

  • The secret of slow human brain growth

    7 hours ago

  • Biotalys achieves significant progress in manufacturing capabilities for Evoca

    1 day ago

  • Oxurion announces second amendment to Negma Funding Program

    1 day ago